Both oxidative stress-dependent and independent effects of amyloid β protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay

Brain Research

Volumn 830, Issue 1, 1999, Pages 146-154

  Abe, Kazuho ^a   Saito, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

3 (4,5 Dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide reduction assay; Amyloid protein; Cell death; Exocytosis; Oxidative stress; Rat hippocampal neurons

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; ANTIOXIDANT; CATALASE; FORMAZAN; GALLIC ACID PROPYL ESTER; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; TROLOX C;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EXOCYTOSIS; HIPPOCAMPUS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; COLORING AGENTS; EXOCYTOSIS; FORMAZANS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0033614679     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01421-3     Document Type: Article

References (18)

1. 2+-dependent late phase. J. Neurochem. 67:1996;2074-2078.
2. Abe K., Saito H. Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci. Res. 31:1998;295-305.
3. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
4. Dore S., Kar S., Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. USA. 94:1997;4772-4777.
5. Harris M.E., Hensley K., Butterfield D.A., Leedle R.A., Carney J.M. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131:1995;193-202.
6. Kato M., Saito H., Abe K. Nanomolar amyloid β protein-induced inhibition of cellular redox activity in cultured astrocytes. J. Neurochem. 68:1997;1889-1895.
7. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:1997;581-593.
8. Liu Y., Peterson D.A., Schubert D. Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. USA. 95:1998;13266-13271.
9. Liu Y., Schubert D. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J. Neurochem. 69:1997;2285-2293.
10. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilization and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
11. May P.C., Gitter B.D., Waters D.C., Simmons L.K., Becker G.W., Small J.S., Robinson P.M. β-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging. 13:1992;605-607.
12. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vivo aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
13. Poirier J. Apolipoprotein E in animal model of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
14. Ren R.F., Flanders K.C. Transforming growth factor-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide. Brain Res. 732:1996;16-24.
15. Shearman M.S., Regan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
16. Ueda K., Fukui Y., Kageyama H. Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein. Brain Res. 639:1994;240-244.
17. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
18. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 25:1990;279-282.